Kaplan-Meier data showed that a higher CTSV expression could decrease the overall survival and disease-free survival of BCa patients, indicating an important role of CTSV in bladder cancer progression, which could be used as a potential prognostic biomarker and therapeutic target in bladder cancer. The gene discussed is CTSV; the disease is urinary bladder cancer.